Arkolith/Insider Trading/XENE/Form 4

Mortimer Ian

PRESIDENT & CEO, DirectorXenon Pharmaceuticals Inc. (XENE) · full profile →Form 4 · filed Dec 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 28, 2025Sell(S)97$45.01$4K31K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-307211) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML